The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

2001 Grand Rounds: Molecular Oncology Symposium



Sort by: presentation order title speaker
Search Virtual Meeting

PRESENTATON TITLE SPEAKER/ROLE MEDIA
Cancer treatment in the STI-571 Era-what will change?
Charles L. Sawyers, MD
Speaker
Video & Slides
Changes in Clinical Trial Design for Molecular Targeted Agents
Jaap Verweij, MD, PhD
Speaker
Video & Slides
Clinical Investigation of PK/PD Relationship for Glivec (STI 571)
Bin Peng, MD, PhD
Speaker
Video & Slides
STI 571 in the Treatment of Pediatric Philadelphia (PH+) Chromosome-Positive Leukemia: A Childrens Oncology Group Phase 1 Study (P-9973)
George D. Demetri, MD
Speaker
Video & Slides
Targeting the KIT Tyrosine Kinase with STI571 (Gleevec, Imatnib meslylate) in Solid Tumors: Getting the GIST of it
Martin A. Champagne, MD
Speaker
Video & Slides
The Role of STI571 (Gleevec), A Specific Inhibitor of the ABL Tyrosine Kinase,In the Management of Chronic Myelogenous Leukemia
Charles A. Schiffer, MD
Speaker
Video & Slides




This online resource is supported by:
Primary Supporter  


 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.